Iridex Reports First Quarter 2026 Financial Results
Iridex Corporation announced its first quarter 2026 financial results, reporting total revenue of $11.8 million, slightly down 1% year-over-year. Growth in its glaucoma product line and service revenues partially offset a decline in retina product sales due to international supply constraints and regulatory delays. The company reduced operating exp…